1493 studies found for:    "Sexually Transmitted Diseases, Viral"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
4 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
5 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
6 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
7 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
8 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
9 Not yet recruiting A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction
Conditions: HIV (Human Immuno-Deficiency Virus);   Renal Impairment;   ESRD (End-Stage Renal Disease)
Intervention: Drug: Oral BMS-663068 (pro-drug), metabolized to active BMS-626529
10 Completed Dose Optimisation of Stavudine for the Treatment of HIV Infection
Conditions: Acquired Immune Deficiency Syndrome;   Human Immunodeficiency Virus
Interventions: Drug: Stavudine;   Drug: Tenofovir Disoproxil Fumarate
11 Not yet recruiting Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: Placebo for VRC01
12 Not yet recruiting HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection
Conditions: Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: E/C/F/TAF;;   Drug: Ledipasvir-Sofosbuvir
13 Not yet recruiting Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs
Condition: Human Immunodeficiency Virus
Intervention: Drug: dolutegravir/abacavir/lamivudine
14 Not yet recruiting Metformin Immunotherapy in HIV Infection
Condition: HIV Infection
Intervention: Drug: Metformin
15 Recruiting Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
Condition: HIV
Interventions: Drug: Dolutegravir;   Drug: Emtricitabine/Tenofovir
16 Recruiting Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia
Condition: Human Immunodeficiency Virus
Interventions: Drug: Boosted atazanavir;   Drug: Lamivudine
17 Recruiting CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
Condition: HIV, Inflammation
Interventions: Drug: Assess Safety;   Drug: Effect of drug on viral load;   Drug: Effect of drug on T-cell count;   Drug: Effect of drug on inflammatory biomarkers
18 Not yet recruiting Safety and Efficacy of Allogenic Adoptive Cell Therpy for Immunodeficiency in Chronic HIV-1 Infected Patients
Conditions: Human Immunodeficiency Virus;   Immunosuppression
Interventions: Other: Conventional plus AAC treatment;   Other: Conventional plus placebo treatment
19 Not yet recruiting Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
Conditions: Hepatitis C;   Human Immunodeficiency Virus
Interventions: Drug: ledipasvir and sofosbuvir;   Drug: Placebo (for ledipasvir and sofosbuvir)
20 Not yet recruiting Safety and Efficacy of Allogenic Adoptive Cell Therpy for Immune Reconstitution in Chronic HIV-1 Infected Patients
Conditions: Human Immunodeficiency Virus;   Disorder of Immune Reconstitution
Interventions: Other: Conventional plus AAC treatment;   Other: Conventional plus placebo treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years